Pomalidomide Impurity 23 | CAS 52806-20-9 - Request Quote
Pomalidomide Impurity 23
| SZ CAT No: | SZ-P055039 |
| CAS No | 52806-20-9 |
| Mol.F. | C8H2N2O7 |
| Mol.Wt. | 238.1 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Pomalidomide Impurity 23 is chemically 4,6-Dinitroisobenzofuran-1,3-dione. Pomalidomide Impurity 23 is supplied with detailed characterization data compliant with regulatory guideline. Pomalidomide Impurity 23 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pomalidomide.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 52806-20-9
Purchase 52806-20-9
Order 52806-20-9
Enquire 52806-20-9
price of 52806-20-9
52806-20-9 Supplier
52806-20-9 Manufacturer
52806-20-9 Exporter
buy high quality Pomalidomide Impurity 23
Purchase Pomalidomide Impurity 23
Pomalidomide Impurity 23 suppliers
Pomalidomide Impurity 23 manufacturers
Pomalidomide Impurity 23 price
Order Pomalidomide Impurity 23
Enquire Pomalidomide Impurity 23
Pomalidomide Impurity 23 cost
Pomalidomide Impurity 23 Supplier
Pomalidomide Impurity 23 Distributor
Pomalidomide Impurity 23 for Method Validation
Pomalidomide Reference Standard
Pomalidomide Impurity 23 for ANDA Filing
Pomalidomide Impurity 23 for Forced Degradation Studies
Pomalidomide Impurity 23 Identification Standards
Pomalidomide Impurity 23 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.